Tenaya Therapeutics TNYA
NASDAQ TNYA
$0.57 -0.04 (-6.28%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tenaya Therapeutics (TNYA) Other Non-Current Liabilities (2020 - 2026)

Updated

Tenaya Therapeutics' Other Non-Current Liabilities was $103,000 in Q2 2026, down 64.8% from $293,000 a year earlier and down 75.4% from the prior quarter.

Analysis

Tenaya Therapeutics (TNYA) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Other Non-Current Liabilities at Tenaya Therapeutics came in at $410,000, up 45.9% from FY2024.

  • Other Non-Current Liabilities has now increased for five consecutive years, with a five-year compound annual growth rate of 84.8% (FY2020 to FY2025).
  • In earlier years, Other Non-Current Liabilities was $281,000 in FY2024 (+11.1%), $253,000 in FY2023 (+11.0%), $228,000 in FY2022 (+25.3%) and $182,000 in FY2021 (+857.9%).
  • The Q2 2026 figure marks the lowest quarterly Other Non-Current Liabilities since Q3 2021.
  • Compared with a year earlier, Other Non-Current Liabilities was higher in seven of the last eight quarters, with growth averaging 10.0%.
  • The best year-over-year quarter for Other Non-Current Liabilities over five years was Q4 2021 (growth of 857.9%); the worst was Q2 2026 (a decline of 64.8%).
  • Per Business Quant data, TNYA's Other Non-Current Liabilities in the three quarters before Q2 2026 was $418,000 (Q1 2026), $410,000 (Q4 2025) and $301,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Tenaya Therapeutics 134.54 Mn 134.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 103,000.00
Mar 31, 2026 418,000.00
Dec 31, 2025 410,000.00
Sep 30, 2025 301,000.00
Jun 30, 2025 293,000.00
Mar 31, 2025 287,000.00
Dec 31, 2024 281,000.00
Sep 30, 2024 276,000.00
Jun 30, 2024 266,000.00
Mar 31, 2024 259,000.00
Dec 31, 2023 253,000.00
Sep 30, 2023 246,000.00
Jun 30, 2023 240,000.00
Mar 31, 2023 234,000.00
Dec 31, 2022 228,000.00
Sep 30, 2022 223,000.00
Jun 30, 2022 217,000.00
Mar 31, 2022 212,000.00
Dec 31, 2021 182,000.00
Sep 30, 2021 96,000.00
API Access

Tenaya Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TNYA&period=max&api_key=YOUR_API_KEY